Breast cancer
Conditions
Interventions
group 1:D-TACE
Sponsors
Suining Central Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Female patients aged 18-75 years; 2. Pathologically or histologically diagnosed patients with advanced clinical stage of primary breast cancer who are willing to downstage breast conserving patients, or patients who are inoperable and expected to be downstaged to be operable; 3. Patients who have no chance of surgery or resist surgical resection; 4. ECOG score 0-2, Child-Pugh class A or B; 5. Breast cancer patients who have not received other treatments within one month after initial diagnosis and progression; 6. Patients volunteered to participate in this trial.
Exclusion criteria
Exclusion criteria: 1. Pathological classification of patients who are not suitable for using epirubicin as a chemotherapy drug; 2. Patients with multiple organ malignant tumors; 3. People with mental illness and behavioral disorder; 4. Those who are allergic to contrast media; 5. Severe coagulation dysfunction (international normalized ratio exceeds or activated partial thromboplastin time exceeds the upper limit of normal by more than 2 times); 6. Serious infections that cannot be corrected after treatment; 7. Patients with severe cardiopulmonary insufficiency who cannot tolerate the operation; 8. Those with cachexia or multiple organ failure; 9. Pregnant or lactating women; 10. The investigator believes that any situation that will interfere with the evaluation of the efficacy of the trial, or interfere with the safety of the subjects, or interfere with the results of the trial; 11. Subjects deemed unsuitable by the investigator to be treated with this regimen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| objective response rate;disease control rate; | — |
Countries
China
Contacts
Public ContactQin Wei
Suining Central Hospital
Outcome results
None listed